Genticel appoints vice president


November 8, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genticel, moeller
Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …
UK to launch DNA database
November 8, 2013Sales and Marketing DNA, UK, crispr, genome
Volunteers prepared to share their DNA with the rest of the world are being sought by scientists in the UK, …
Alzheimer’s drug development ‘must speed up’
November 7, 2013Research and Development, Sales and Marketing Alzheimer's, CEO, drug development
Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …
Shire to cut UK research jobs says source
November 7, 2013Research and Development, Sales and Marketing England, Shire, UK, cuts
Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …
PPRS: thumbs-down from pharma
November 7, 2013Sales and Marketing ABPI, NHS, PPRS, Pfizer, VBP
A missed opportunity for patients, which creates financial problems for smaller companies while stifling life science investment – these are …
Biotec Services expands with new appointments
November 7, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotec services
Clinical trials services firm Biotec Services International is expanding its presence in the US and the UK with three new …
£10 million boost for synthetic biology
November 6, 2013Research and Development, Sales and Marketing Biological, Synthetic, biotech
The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …
PPRS to remain in UK, but drug growth curbed
November 6, 2013Sales and Marketing ABPI, DH, Deepak Khanna, NHS, PPRS
The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …
inVentiv Health acquires Catalina Health
November 6, 2013Medical Communications Adheris, catalina, inVentiv Health
Consulting and services company inVentiv Health has acquired a subsidiary of Catalina (Catalina Health) and joined it onto its own …
ImmunoGen stops cancer trial
November 6, 2013Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche
Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …
Profil Institute hires former Amylin chief executive
November 6, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amylin, profil institute
Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors. “Dan Bradbury …
UK is the go-to place for developing medicines
November 5, 2013Research and Development, Sales and Marketing BIA, Cell Medica, ReNeuron, UK
The BioIndustry Association (BIA) has said that the UK is clearly the must-go-to location for regenerative medicine research and development. …
J&J hit with $2.2 billion fine
November 5, 2013Sales and Marketing J&J, JJ, Janssen, Risperdal, antipsychotic, fine
Johnson & Johnson has admitted promoting its big-selling antipsychotic drug Risperdal off-label, costing the firm $2.2 billion in fines. The …
BMS files oral hep C treatment
November 5, 2013Sales and Marketing BMS, HCV, dvc, hep C
Bristol-Myers Squibb has filed its investigational hepatitis C treatment – the first oral regime without interferon or ribavirin – with …
Astellas poaches comms head from Lilly
November 5, 2013Astellas has hired Jeffrey Winton from Eli Lilly to be its senior vice president and chief communications officer.Winton who will …
GSK ‘may not face corporate charges’
November 5, 2013Medical Communications, Sales and Marketing China, GSK, bribery
GlaxoSmithKline is unlikely to face a company-wide charge for corruption following investigations by authorities in China according to reports. The …
GSK: no Votrient Code breaches
November 4, 2013Medical Communications, Sales and Marketing GSK, PMCPA, Pfizer
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
